HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Paediatric skin cancer, a rare and often overlooked subset of malignancies, manifests itself as an assortment of neoplastic conditions affecting the skin in children, presenting unique challenges in diagnosis, treatment, and long-term management. Contrary to prevailing misconceptions, children are not immune to the development of skin cancer, with the most prevalent types being melanoma, basal cell carcinoma, and squamous cell carcinoma. The etiological factors contributing to Paediatric skin cancer are multifaceted, ranging from genetic predispositions and underlying medical conditions to intense ultraviolet (UV) exposure. Identifying these cancers in children can be particularly challenging due to the rarity of cases and the varied clinical presentations that may mimic benign dermatologic conditions. Early detection is pivotal, as delayed diagnosis may lead to advanced disease stages with potentially devastating consequences. Treatment modalities encompass a multidisciplinary approach, involving Paediatric oncologists, dermatologists, surgeons, and radiation oncologists, tailored to the specific type, stage, and location of the cancer. In addition to surgical interventions, novel targeted therapies and immunotherapies show promise in addressing Paediatric skin cancer while minimizing systemic side effects. Long-term follow-up and surveillance are imperative, considering the potential for recurrence and the impact of treatments on a child's growing body. Comprehensive patient and family education regarding sun protection practices, regular skin examinations, and genetic counseling are essential components of holistic care. Collaborative efforts between healthcare providers, researchers, and advocacy groups are crucial to enhance our understanding of Paediatric skin cancer, refine diagnostic approaches, and advance treatment strategies, ultimately improving outcomes for this vulnerable patient population.
